Teratology Study Guidelines: An Overview.

Developmental toxicology is a constantly evolving research field which needs to attend to a complex underlying regulatory network. Before entering the market new substances have to be tested for toxic effects on reproduction and development in order to ensure human health and environmental safety. Traditional in vivo mammalian models represent more adequately the intricacy of human development and provide an assessment of the interaction of chemicals on the reproductive system. However, in the last years, the main goal is to reduce the use of vertebrate animals, using those only as last resort. Consequently, the interest in the development and validation of a battery of alternative tests able to cover the various aspects of the reproductive cycle has increased. Reproductive toxicity is probably the most difficult endpoint to be replaced by alternative assays, since it should provide information on mechanisms interactions essential for female and male fertility, and also knowledge on the development of a new human being during its prenatal life. This complexity explains the slow progress in implementing alternatives for reproductive toxicity safety assessments. Alternative test methods may be based on in vitro systems and non-mammalian animal models. Many biological processes have been successfully implemented using in vitro models, opening the possibility to study the interference of teratogenic compounds using these models. Their validation and implementation have lagged behind, in part because of difficulties in establishing their predictability. Nevertheless, the advance toward the process of validation is crucial for a strategy aiming to replace and reduce the use of living animals. Based on the present state of the art, it is not probable that such testing strategies will completely replace the need to assess reproductive toxicity in vivo in the near future, but they contribute to reduce the animal testing and provide important information. In this chapter the approved guidelines for standard methods and alternative methods according to their regulatory and scientific status are enumerated and described.

[1]  Toshihiko Ogura,et al.  Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.

[2]  I. Tessaro,et al.  Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test. , 2015, Reproductive toxicology.

[3]  Darrell R Boverhof,et al.  Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing. , 2015, Journal of the American Association for Laboratory Animal Science : JAALAS.

[4]  P. Myllynen,et al.  Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues , 2009, Expert opinion on drug metabolism & toxicology.

[5]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[6]  M. Aschner,et al.  Unmasking silent neurotoxicity following developmental exposure to environmental toxicants. , 2016, Neurotoxicology and teratology.

[7]  R. Tyl In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines. , 2010, Birth defects research. Part C, Embryo today : reviews.

[8]  Stuart Creton,et al.  Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation. , 2013, Regulatory toxicology and pharmacology : RTP.

[9]  Hilda Witters,et al.  Zebrafish embryos as an alternative to animal experiments--a commentary on the definition of the onset of protected life stages in animal welfare regulations. , 2012, Reproductive toxicology.

[10]  M. Spanô,et al.  ReProComet: a new in vitro method to assess DNA damage in mammalian sperm. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Robert J Kavlock,et al.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.

[12]  Aldert H Piersma,et al.  Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[13]  Michael Schwarz,et al.  The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. , 2005, Reproductive toxicology.

[14]  J. Sulston,et al.  The embryonic cell lineage of the nematode Caenorhabditis elegans. , 1983, Developmental biology.

[15]  J. Sulston,et al.  Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. , 1977, Developmental biology.

[16]  Penelope A. Fenner-Crisp,et al.  Key Elements for Judging the Quality of a Risk Assessment , 2016, Environmental health perspectives.

[17]  Jesper B Nielsen,et al.  Placental transport and in vitro effects of Bisphenol A. , 2010, Reproductive toxicology.

[18]  S. Zottoli,et al.  Recovery of C-starts, equilibrium and targeted feeding after whole spinal cord crush in the adult goldfish Carassius auratus , 2003, Journal of Experimental Biology.

[19]  M. De Felici,et al.  Estrogenic in vitro assay on mouse embryonic Leydig cells. , 2010, The International journal of developmental biology.

[20]  Christian Beste,et al.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. , 2012, Neurotoxicology.

[21]  G. Calo’,et al.  Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112 , 2010, PAIN.

[22]  Aldert Piersma,et al.  The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.

[23]  L. Knudsen,et al.  Placental Passage of Benzoic acid, Caffeine, and Glyphosate in an Ex Vivo Human Perfusion System , 2008, Journal of toxicology and environmental health. Part A.

[24]  Thomas Braunbeck,et al.  Zebrafish (Danio rerio) embryos as a model for testing proteratogens. , 2011, Toxicology.

[25]  S. Bremer,et al.  Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella. , 2008, Toxicology and applied pharmacology.

[26]  Aldert Piersma,et al.  Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement , 2016, Archives of Toxicology.

[27]  Aldert H Piersma,et al.  Alternative methods for developmental toxicity testing. , 2006, Basic & clinical pharmacology & toxicology.

[28]  P. Barrow Revision of the ICH guideline on detection of toxicity to reproduction for medicinal products: SWOT analysis. , 2016, Reproductive toxicology.

[29]  D. Fort,et al.  Enhancing the predictive validity of Frog Embryo Teratogenesis Assay—Xenopus (FETAX) , 2002, Journal of applied toxicology : JAT.

[30]  O. Flint,et al.  In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. , 1993, Reproductive toxicology.

[31]  Ruud Woutersen,et al.  Zebrafish as potential model for developmental neurotoxicity testing: a mini review. , 2012, Neurotoxicology and teratology.

[32]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[33]  B. Edgar,et al.  Cell cycle control by the nucleo-cytoplasmic ratio in early Drosophila development , 1986, Cell.

[34]  John M DeSesso,et al.  Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison. , 2004, Birth defects research. Part C, Embryo today : reviews.

[35]  C. Scudamore,et al.  International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies , 2010, Journal of toxicologic pathology.

[36]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[37]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[38]  R. Dietert Developmental immunotoxicology: focus on health risks. , 2009, Chemical research in toxicology.

[39]  R. Cortvrindt,et al.  The antibiotic streptomycin assessed in a battery of in vitro tests for reproductive toxicology. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[40]  Aldert Piersma,et al.  A Review of the Implementation of the Embryonic Stem Cell Test (EST) , 2009, Alternatives to laboratory animals : ATLA.

[41]  Markus Reischl,et al.  Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. , 2009, Reproductive toxicology.

[42]  Menghang Xia,et al.  Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  S. Bremer,et al.  Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect. , 2010, Reproductive toxicology.

[44]  O. Tooi,et al.  Availability of in vitro vitellogenin assay for screening of estrogenic and anti-estrogenic activities of environmental chemicals. , 2006, Environmental sciences : an international journal of environmental physiology and toxicology.

[45]  J. Pennings,et al.  Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  Carsten Kneuer,et al.  Relevance and reliability of experimental data in human health risk assessment of pesticides , 2017, Regulatory toxicology and pharmacology : RTP.

[47]  D. Kochhar In vitro testing of teratogenic agents using mammalian embryos. , 1980, Teratogenesis, carcinogenesis, and mutagenesis.

[48]  C. Schleh,et al.  How to optimize the benefits of computer assisted sperm analysis in experimental toxicology , 2013, Journal of Occupational Medicine and Toxicology.

[49]  Lisbeth Ehlert Knudsen,et al.  The human placenta--an alternative for studying foetal exposure. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[50]  R. Altenburger,et al.  Suborganismic and organismic effects of aldicarb and its metabolite aldicarb-sulfoxide to the zebrafish embryo (Danio rerio). , 2007, Chemosphere.

[51]  Julia Schumann Teratogen Screening: State of the Art , 2010, Avicenna journal of medical biotechnology.

[52]  I. Mouche,et al.  FETAX assay for evaluation of developmental toxicity. , 2011, Methods in molecular biology.

[53]  Julieta M. Panzica-Kelly,et al.  Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[54]  M. Dorato,et al.  Reproductive and developmental toxicity testing: Examination of the extended one-generation reproductive toxicity study guideline. , 2016, Regulatory toxicology and pharmacology : RTP.

[55]  P. Hunt The C. elegans model in toxicity testing , 2016, Journal of applied toxicology : JAT.

[56]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[57]  Jens C. Otte,et al.  The fish embryo test (FET): origin, applications, and future , 2015, Environmental Science and Pollution Research.

[58]  L. Wise The ICH S5(R2) guideline for the testing of medicinal agents. , 2013, Methods in molecular biology.

[59]  Wim De Coen,et al.  Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. , 2009, Reproductive toxicology.

[60]  A. Fantel Culture of whole rodent embryos in teratogen screening. , 1982, Teratogenesis, carcinogenesis, and mutagenesis.